By Tandem HealthLearning Objectives
- Understand what an ambient AI scribe does and where Tandem fits in the European market
- Explain why Tandem's Class IIa certification matters, and what it does and does not prove
- Judge which of Tandem's plans, if any, fits a solo clinician, a practice or a health system
What Is Tandem?
Tandem is an ambient AI medical scribe from Tandem Health, a Stockholm company founded in 2023. During a consultation it listens to the conversation between clinician and patient, transcribes it, and drafts a structured clinical note and any follow-up documents, which the clinician reviews, edits and transfers into the medical record before the next patient. Tandem says the conversation can happen in the patient's language while the note is generated in the language the clinician chooses.
The scribe sits inside a broader product the company calls an AI medical assistant, which adds a coding assistant for turning a visit into diagnosis and procedure codes and a clinical decision support tool that answers questions with linked sources. Tandem is built for Europe first: it sells across 14 European markets, says it connects to more than 130 medical record systems, and reaches NHS clinicians in the UK through Accurx Scribe, powered by Tandem, a partnership with the UK software company Accurx announced in April 2025.
⚠️Warning
Who can use it, and under which rules. Tandem is sold in Europe and the UK, and its site describes no offering in the United States. The scribe is CE marked as a Class IIa medical device under the EU Medical Device Regulation, a European certification; the pages reviewed do not state a separate UK or US regulatory status. The clinical decision support tool is in early access for selected customers only. Published Pro pricing is in euros, and the self-serve plans are aimed at clinicians rather than patients.
💡Key Concept
Why the device class matters: under the EU Medical Device Regulation, a Class I product can be self-certified by its maker, while Class IIa requires an independent notified body to audit the clinical, technical and AI-specific evidence. Sweden's Medical Products Agency concluded after an inspection that classifying Tandem's scribe as Class I was not compatible with the regulation. Tandem argues that reasoning applies to every AI scribe drafting clinical notes; that is the company's reading, not a ruling on its competitors.
🎯Tip
Visit Tandem: tandemhealth.ai offers a free sign-up for clinicians and demo bookings for practices and care organisations.
Pricing
Unusually for a clinical scribe, Tandem publishes its prices. A free plan and a Pro plan can be started without talking to sales; larger organisations get a quote.
- Unlimited note generation
- Up to two custom templates
- Invite up to two co-workers
- Limited daily Pro Actions
- Unlimited notes, documents and templates
- Unlimited Pro Actions and personalisation
- 1-click transfer to 100+ record systems
- Clinician-led support
- Everything in Pro, plus custom integrations
- Full onboarding, training and rollout
- Single sign-on and user provisioning
- Detailed usage reports
Monthly billing is also offered for Pro, and paying yearly saves 15 percent. The company says free licences can be arranged for administrative staff.
Core Features
Ambient Note Generation
Tandem listens to the consultation, transcribes it and drafts the note in the structure the clinician needs, ready to edit and transfer. Clinicians can build their own note templates, a feature added in March 2026.
Personalised Memories
Since April 2026 Tandem learns how an individual clinician writes, so later drafts follow that person's phrasing and structure rather than a generic house style.
Coding Assistant
A separate module suggests the diagnosis and procedure codes a visit needs for reporting and reimbursement. It was certified as a Class IIa medical device in February 2026, and Tandem says it is built to support each country's own coding framework.
Clinical Decision Support
Launched in June 2026 for selected customers, it lets a clinician ask a question during the visit and receive an answer specific to the patient, drawn from medical literature, national guidelines and the organisation's own uploaded protocols, with every answer linked to its source.
Hardware and Integrations
Tandem works on a phone or a computer and, since June 2026, with the Philips SpeechMike Ambient wireless microphone. Pro includes one-click transfer into supported record systems, and Enterprise adds custom integrations.
Strengths
- Independently audited — the scribe, coding assistant and decision support tool are each certified Class IIa under the EU Medical Device Regulation, rather than self-certified
- Transparent pricing — a free plan and a published Pro price, where most clinical scribes quote only on request
- European reach — sold across 14 European markets, with integrations into more than 130 medical record systems, according to the company
- Large public-sector distribution — Accurx Scribe, powered by Tandem, was made available to more than 200,000 NHS professionals
- Real-world evidence — a Capio evaluation of 375,000 notes from 1,295 clinicians reported a 29 percent drop in documentation time
Limitations and Considerations
- Europe and the UK only — there is no described United States offering, and the certification is a European one
- Evidence is early and not independent — the Capio evaluation was run by a healthcare group whose clinicians use the tool and was posted as a preprint, not a peer-reviewed paper
- Access is not usage — the 200,000 NHS figure counts people who can use the scribe, not people who do
- Certification is not accuracy — a Class IIa audit checks the evidence and processes behind a device; it does not guarantee a given note is correct, so the clinician still reviews and signs every one
- Decision support is early access — the clinical question-answering tool is not generally available
- Pro is priced for professionals — at 125 euros per user per month on yearly billing, a solo clinician should test the free plan first
Best Use Cases
| Use Case | Why Tandem Fits | Caveat |
|---|---|---|
| Solo clinicians trying AI scribing | Free plan with unlimited notes | Pro Actions are limited daily |
| European practices and clinics | Self-serve Pro and local record integrations | Check your record system is supported |
| NHS GP practices and trusts | Available through Accurx Scribe | Procurement runs through Accurx or the trust |
| Health systems needing certified tools | Class IIa under the EU MDR | European certification, not US |
| Multilingual consultations | Note generated in the clinician's chosen language | Verify accuracy per language |
Clinicians comparing options can look at Abridge, which built its lead in American health systems through deep Epic integration, Nabla, a Paris-based scribe that also competes for European buyers, and Suki AI, a voice-driven documentation assistant integrated with American record systems such as Epic.
Key Takeaways
- Tandem is an ambient AI medical scribe from Stockholm's Tandem Health that drafts structured clinical notes from a consultation for the clinician to review
- In May 2026 it became, by the company's account, the first AI scribe in Europe certified as a Class IIa medical device under the EU Medical Device Regulation
- It reaches NHS clinicians through Accurx Scribe, powered by Tandem, and is sold across 14 European markets
- A free plan and a Pro plan at 125 euros per user per month on yearly billing are self-serve, with enterprise pricing on request
- The headline 29 percent time saving comes from a customer's evaluation posted as a preprint, so treat it as promising rather than proven
